What is Decide?
Established in 2015, Decide serves as a critical bridge between complex health data and actionable policy decisions. The firm specializes in health economics, cost-benefit analyses, and the evaluation of healthcare programs, providing essential insights to drug manufacturers, non-profit organizations, and public sector stakeholders. By integrating both qualitative and quantitative methodologies, Decide enables decision-makers to navigate the intricacies of health technology assessment with precision.
The company's competitive advantage is rooted in its collaborative ecosystem, which includes strategic alliances with established entities such as COWI and the Swedish Institute for Health Economics. This network allows Decide to deliver high-fidelity real-world evidence studies that are vital for regulatory compliance and market access strategies. As the healthcare industry shifts toward value-based care, Decide remains a pivotal player in defining the economic viability of new medical interventions.
How much funding has Decide raised?
Decide has raised a total of $16.5M across 3 funding rounds:
Series A
$2.5M
Series B
$6M
Series C
$8M
Series A (2009): $2.5M with participation from Madrona Venture Group
Series B (2011): $6M led by Madrona Venture Group and Maveron LLC
Series C (2013): $8M supported by Maveron and Madrona Venture Group
Key Investors in Decide
Madrona Venture Group
Founded in 1995, Madrona Venture Group is a venture capitalist investment company including consumer internet, commercial software, and services.
Maveron LLC
Maveron is a consumer-only venture capital firm that partners with innovative entrepreneurs to transform consumer experiences and industries, holding a B Corp certification.
What's next for Decide?
Looking ahead, the strategic deployment of the $8M investment will likely focus on scaling Decide's proprietary analytical frameworks and expanding its reach into new international markets. As healthcare systems globally grapple with rising costs and the need for sustainable service delivery, the demand for the firm's specialized consulting services is expected to accelerate.
The company is poised to enhance its technological infrastructure, potentially incorporating advanced data modeling tools to further refine its cost-analysis capabilities. By maintaining its focus on high-impact health economic projects and fostering its existing institutional partnerships, Decide is set to solidify its role as an indispensable advisor in the health technology and welfare sectors. The firm's ability to translate complex data into strategic policy recommendations will remain its primary driver for long-term growth and industry influence.
